Banque Cantonale Vaudoise’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Sell |
1,155
-1,419
| -55% | -$745K | 0.02% | 418 |
|
|
2025
Q1 | $1.63M | Buy |
+2,574
| New | +$1.63M | 0.07% | 272 |
|
|
2024
Q3 | $858K | Sell |
817
-621
| -43% | -$652K | 0.04% | 340 |
|
|
2024
Q2 | $1.51M | Sell |
1,438
-3,225
| -69% | -$3.39M | 0.06% | 276 |
|
|
2024
Q1 | $4.49M | Buy |
4,663
+1,167
| +33% | +$1.12M | 0.18% | 117 |
|
|
2023
Q4 | $3.07M | Sell |
3,496
-402
| -10% | -$353K | 0.13% | 155 |
|
|
2023
Q3 | $3.21M | Buy |
3,898
+310
| +9% | +$255K | 0.16% | 108 |
|
|
2023
Q2 | $2.58M | Sell |
3,588
-2,688
| -43% | -$1.93M | 0.12% | 144 |
|
|
2023
Q1 | $5.16M | Buy |
6,276
+3,670
| +141% | +$3.02M | 0.25% | 77 |
|
|
2022
Q4 | $1.88M | Sell |
2,606
-2,059
| -44% | -$1.49M | 0.1% | 193 |
|
|
2022
Q3 | $3.21M | Sell |
4,665
-10
| -0.2% | -$6.89K | 0.18% | 101 |
|
|
2022
Q2 | $2.76M | Buy |
4,675
+1,583
| +51% | +$936K | 0.14% | 136 |
|
|
2022
Q1 | $2.16M | Sell |
3,092
-2,075
| -40% | -$1.45M | 0.09% | 214 |
|
|
2021
Q4 | $3.26M | Buy |
5,167
+1,604
| +45% | +$1.01M | 0.13% | 152 |
|
|
2021
Q3 | $2.16M | Sell |
3,563
-219
| -6% | -$133K | 0.09% | 214 |
|
|
2021
Q2 | $2.11M | Buy |
3,782
+135
| +4% | +$75.4K | 0.09% | 219 |
|
|
2021
Q1 | $1.73M | Buy |
3,647
+425
| +13% | +$201K | 0.09% | 223 |
|
|
2020
Q4 | $1.56M | Sell |
3,222
-430
| -12% | -$208K | 0.09% | 207 |
|
|
2020
Q3 | $2.05M | Sell |
3,652
-1,538
| -30% | -$861K | 0.13% | 143 |
|
|
2020
Q2 | $3.24M | Buy |
5,190
+2,695
| +108% | +$1.68M | 0.24% | 88 |
|
|
2020
Q1 | $1.22M | Buy |
2,495
+1,243
| +99% | +$607K | 0.1% | 200 |
|
|
2019
Q4 | $471K | Buy |
+1,252
| New | +$471K | 0.03% | 485 |
|